Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/26/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Thomas Hecht?

Thomas Hecht

Vice President of Marketing

Amgen Inc.

HQ Phone:  (805) 447-1000

Direct Phone: +41 ** *** ** **direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Amgen Inc.

One Amgen Center Dr.

Thousand Oaks, California,91320

United States

Company Description

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to u...more

Background Information

Employment History

Chairman

Cell Medica Limited


Chairman

Affimed N.V.


Co-Head of the Program for Bone Marrow Transplantation

University of Freiburg


Chairman

VAXIMM AG


Executive Chairman

Delenex Therapeutics AG


Founder and Owner

Hecht Healthcare Consulting


Chairman

ESBATech AG


Affiliations

SuppreMol GmbH

Chairman of the Supervisory Council


Humabs BioMed SA

Director


Kuros Biosciences Ltd

Board Member


Clovis Oncology, Inc.

Board Member


German Kidney Foundation Support Society

Chairman of the Investors Advisory Board


Heidelberg Innovation

Chairman of the Investors Advisory Board


Cytos Biotechnology AG

Vice Chairman


R&D Directions

Chairman of the Supervisory Board


Cytos Biotechnology AG

Board Member


Education

MD


MD

University of Freiburg


degree

Economics


Web References(92 Total References)


Cell Medica - Dr Kurt Gunter

cellmedica.com [cached]

Dr Thomas Hecht
Chairman Thomas is Chairman of the Supervisory Board since 2012. He was previously Vice President Marketing at Amgen Europe, Lucerne, Switzerland. Following his academic career, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany. Today, he provides services to the pharmaceutical industry in clinical development/ marketing and licensing strategies. He also serves as Chairman of Affimed N.V., Vaximm AG and as Member of the Board of Humabs BioMed AG. In 2009, with the acquisition by Alcon, he stepped down from the Chairmanship of ESBATech AG; and in 2015, with the acquisition by Baxter International Inc., from his post as Chairman of the Supervisory Council of SuppreMol GmbH. Thomas earned his MD at the University of Freiburg.


Affimed

www.affimed.com [cached]

Dr. Thomas Hecht, Chairman
Dr. Hecht has been the Chairman of Affimed's Supervisory Board since 2007. He is Head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as Chairman of the Board of Directors of Cell Medica Ltd., Delenex AG, Vaximm AG and as a Director of Humabs BioMed AG. Until the beginning of March 2015, he served as Chairman of the Supervisory Council of SuppreMol GmbH. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.


Cell Medica raises $26.5m · Articles · Global University Venturing

www.globaluniversityventuring.com [cached]

Thomas Hecht, the former vice president of marketing in Europe for Amgen is becoming chairman and UK-based foundation the Wellcome Trust is converting its investment in the company into equity.


VAXIMM company portrait | VAXIMM

www.vaximm.com [cached]

Thomas Hecht, MD
Chairman Thomas Hecht, MD, Chairman is a seasoned manager and has extensive experience in the biopharmaceutical industry. Dr. Hecht is founder and owner of Hecht Healthcare Consulting, which provides marketing, clinical development and mergers & acquisitions services to the pharmaceutical/biotechnology industry. Previously, he was VP Marketing (Hematology, Oncology, New Products) at Amgen Europe. Before that, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen Europe. He currently serves as Chairman of the Boards of Affimed N.V. and Cell Medica Ltd., and as Member of the Board of Humabs BioMed AG. He was previously Chairman of the Boards of ESBATech AG (acquired by Alcon/Novartis in 2009), SuppreMol GmbH (acquired by Baxalta in 2015), and Cytos AG. Prior to joining the biopharmaceutical industry, Dr. Hecht was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation, University of Freiburg, Germany.


www.sec.gov

Thomas Hecht is the chairman of our supervisory board.
Thomas Hecht Thomas Hecht, Chairman. Dr. Hecht has been the chairman of our supervisory board since 2007. He is head of Hecht Healthcare Consulting in Küssnacht, Switzerland, a biopharmaceutical consulting company founded in 2002. Dr. Hecht also serves as chairman of the board of directors of Cell Medica Ltd., Vaximm AG and as a director of Humabs BioMed AG. Until the beginning of March 2015, he served as chairman of the supervisory council of SuppreMol GmbH and until June 2016, of Delenex AG. Dr. Hecht was previously Vice President Marketing at Amgen Europe. A seasoned manager and industry professional, he held various positions of increasing responsibility in clinical development, medical affairs and marketing at Amgen between 1989 and 2002. Prior to joining the biopharmaceutical industry, he was certified in internal medicine and served as Co-Head of the Program for Bone Marrow Transplantation at the University of Freiburg, Germany.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory